• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球 1973-2018 年侵袭性脑膜炎奈瑟菌病疫情的公共卫生管理:系统评价。

Public health management of invasive meningococcal disease outbreaks: worldwide 1973-2018, a systematic review.

机构信息

School of Public Health, The University of Adelaide, Level 4 50 Rundle Mall Plaza, Rundle Mall, Adelaide, South Australia, 5000, Australia.

Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, 5001, Australia.

出版信息

BMC Public Health. 2024 Aug 20;24(1):2254. doi: 10.1186/s12889-024-19740-y.

DOI:10.1186/s12889-024-19740-y
PMID:39164680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11334308/
Abstract

BACKGROUND

Infectious disease outbreaks are an ongoing public health concern, requiring extensive resources to prevent and manage. Invasive Meningococcal Disease (IMD) is a severe outcome of infection with Neisseria meningitidis bacteria, which can be carried and transmitted asymptomatically. IMD is not completely vaccine-preventable, presenting an ongoing risk of outbreak development. This review provides a retrospective assessment of public health management of IMD outbreaks.

METHODS

A systematic search was performed in PubMed and EMBASE. English-language studies reporting on IMD outbreaks and associated public health response were considered eligible. Reporting on key characteristics including outbreak size, duration, location, and public health response were assessed against Strengthening the Reporting of Observational studies in Epidemiology guidelines. A summary of lessons learned and author recommendations for each article were also discussed.

RESULTS

39 eligible studies were identified, describing 35 outbreaks in seven regions. Responses to outbreaks were mostly reactive, involving whole communities over prioritising those at highest risk of transmission. Recent responses identified a need for more proactive and targeted controls. Reporting was inconsistent, with key characteristics such as outbreak size, duration, or response absent or incompletely described.

CONCLUSION

There is a need for clear, comprehensive reporting on IMD outbreaks and their public health response to inform policy and practice for subsequent outbreaks of IMD and other infectious diseases.

摘要

背景

传染病疫情是当前公共卫生关注的一个持续问题,需要大量资源来预防和管理。侵袭性脑膜炎球菌病(IMD)是脑膜炎奈瑟菌感染的严重后果,这种细菌可以无症状携带和传播。IMD 不能完全通过疫苗预防,因此仍然存在暴发的风险。本综述对 IMD 暴发的公共卫生管理进行了回顾性评估。

方法

在 PubMed 和 EMBASE 上进行了系统检索。符合条件的研究为报告 IMD 暴发及相关公共卫生应对措施的英文研究。根据《观察性研究的报告质量评估工具》(Strengthening the Reporting of Observational studies in Epidemiology,STROBE)评估报告关键特征(包括暴发规模、持续时间、地点和公共卫生应对措施)的研究。还讨论了从每篇文章中总结的经验教训和作者建议。

结果

确定了 39 项符合条件的研究,描述了来自七个地区的 35 起暴发。对暴发的反应大多是被动的,涉及整个社区,优先考虑传播风险最高的人群。最近的应对措施表明需要更积极主动和有针对性的控制措施。报告不一致,缺乏或未完整描述暴发规模、持续时间或应对措施等关键特征。

结论

需要对 IMD 暴发及其公共卫生应对措施进行明确、全面的报告,为 IMD 和其他传染病的后续暴发提供信息,以指导政策和实践。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4810/11334308/5d81e228af6e/12889_2024_19740_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4810/11334308/f41b82bcda13/12889_2024_19740_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4810/11334308/5d81e228af6e/12889_2024_19740_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4810/11334308/f41b82bcda13/12889_2024_19740_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4810/11334308/5d81e228af6e/12889_2024_19740_Fig2_HTML.jpg

相似文献

1
Public health management of invasive meningococcal disease outbreaks: worldwide 1973-2018, a systematic review.全球 1973-2018 年侵袭性脑膜炎奈瑟菌病疫情的公共卫生管理:系统评价。
BMC Public Health. 2024 Aug 20;24(1):2254. doi: 10.1186/s12889-024-19740-y.
2
The cost and public health burden of invasive meningococcal disease outbreaks: a systematic review.侵袭性脑膜炎球菌病暴发的成本和公共卫生负担:系统评价。
Pharmacoeconomics. 2013 Jul;31(7):563-76. doi: 10.1007/s40273-013-0057-2.
3
Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile.用 4CMenB 和 MenACWY 对不同脑膜炎球菌疫苗接种策略对智利当前幼儿 MenACWY 国家免疫规划的公共卫生影响进行建模。
Hum Vaccin Immunother. 2021 Dec 2;17(12):5603-5613. doi: 10.1080/21645515.2021.1996808. Epub 2021 Dec 10.
4
Lessons for and from the COVID-19 pandemic response - An appraisal of guidance for the public health management of Invasive Meningococcal Disease.从 COVID-19 大流行应对中吸取的经验教训-对侵袭性脑膜炎球菌病公共卫生管理指南的评估。
J Infect Public Health. 2021 Aug;14(8):1069-1074. doi: 10.1016/j.jiph.2021.06.014. Epub 2021 Jun 25.
5
Meningococcal infections among refugees and immigrants: silent threats of past, present and future.难民和移民中的脑膜炎球菌感染:过去、现在和未来的无声威胁。
Hum Vaccin Immunother. 2020 Nov 1;16(11):2781-2786. doi: 10.1080/21645515.2020.1744979. Epub 2020 Apr 29.
6
Inequalities in the risk and prevention of invasive meningococcal disease in the United States - A systematic literature review.美国侵袭性脑膜炎球菌病的风险和预防不平等现象——系统文献回顾。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2406613. doi: 10.1080/21645515.2024.2406613. Epub 2024 Oct 7.
7
Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature.北美和欧洲老年人侵袭性脑膜炎球菌病:现在是采取行动的时候了吗?文献综述
BMC Public Health. 2022 Feb 23;22(1):380. doi: 10.1186/s12889-022-12795-9.
8
Serogroup B invasive meningococcal disease (IMD) outbreak at a Japanese high school dormitory: An outbreak investigation report from the first IMD outbreak in decades.B 群侵袭性脑膜炎球菌病(IMD)在日本一所高中宿舍爆发:数十年来首例 IMD 爆发的疫情调查报告。
Vaccine. 2021 Apr 8;39(15):2177-2182. doi: 10.1016/j.vaccine.2021.02.034. Epub 2021 Mar 16.
9
The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations.全球脑膜炎球菌倡议会议:全球预防脑膜炎球菌病:流行病学、监测、高毒力菌株、抗生素耐药性和高危人群。
Expert Rev Vaccines. 2019 Jan;18(1):15-30. doi: 10.1080/14760584.2019.1557520. Epub 2018 Dec 27.
10
Management of meningococcal outbreaks: are we using the same language? Comparison of the public health policies between high-income countries with low incidence of meningococcal disease.脑膜炎球菌病暴发的管理:我们是否使用相同的语言?对低发病率国家与高收入国家的公共卫生政策的比较。
Expert Rev Vaccines. 2019 May;18(5):559-574. doi: 10.1080/14760584.2019.1595595. Epub 2019 Apr 4.

引用本文的文献

1
Prevalence and Risk of Meningococcal Disease or Carriage During Mass Gatherings and Associated Travel: Systematic Review and Meta-Analysis.群体性活动及相关旅行期间脑膜炎球菌病或带菌状态的患病率和风险:系统评价与荟萃分析
Trop Med Infect Dis. 2025 Jul 25;10(8):207. doi: 10.3390/tropicalmed10080207.
2
Meningococcal Vaccination in High-Risk Patients: A Systematic Approach to Evaluating Coverage and Patient Catch-Up Through Healthcare Databases.高危患者的脑膜炎球菌疫苗接种:通过医疗数据库评估覆盖率和患者补种的系统方法。
Vaccines (Basel). 2025 Mar 8;13(3):287. doi: 10.3390/vaccines13030287.
3
Genetic variability in strains isolated in a Japanese hospital.

本文引用的文献

1
Lessons for and from the COVID-19 pandemic response - An appraisal of guidance for the public health management of Invasive Meningococcal Disease.从 COVID-19 大流行应对中吸取的经验教训-对侵袭性脑膜炎球菌病公共卫生管理指南的评估。
J Infect Public Health. 2021 Aug;14(8):1069-1074. doi: 10.1016/j.jiph.2021.06.014. Epub 2021 Jun 25.
2
Lessons from a community vaccination programme to control a meningococcal disease serogroup W outbreak in remote South Australia, 2017.2017 年,在南澳大利亚偏远地区,通过社区接种疫苗控制脑膜炎球菌 W 血清群疫情的经验教训。
Western Pac Surveill Response J. 2021 Mar 8;12(1):26-31. doi: 10.5365/wpsar.2019.10.2.002. eCollection 2021 Jan-Mar.
3
日本一家医院分离出的菌株中的基因变异性。
IJID Reg. 2024 Dec 5;14:100511. doi: 10.1016/j.ijregi.2024.100511. eCollection 2025 Mar.
Serogroup B invasive meningococcal disease (IMD) outbreak at a Japanese high school dormitory: An outbreak investigation report from the first IMD outbreak in decades.
B 群侵袭性脑膜炎球菌病(IMD)在日本一所高中宿舍爆发:数十年来首例 IMD 爆发的疫情调查报告。
Vaccine. 2021 Apr 8;39(15):2177-2182. doi: 10.1016/j.vaccine.2021.02.034. Epub 2021 Mar 16.
4
Targeted vaccination campaigns of teenagers after two clusters of B invasive meningococcal disease in Brittany, France, 2017.2017年法国布列塔尼地区出现两起B型侵袭性脑膜炎球菌病聚集性病例后开展的青少年针对性疫苗接种活动。
BMC Public Health. 2020 Sep 10;20(1):1382. doi: 10.1186/s12889-020-09487-7.
5
Case Manifestations and Public Health Response for Outbreak of Meningococcal W Disease, Central Australia, 2017.2017 年,澳大利亚中部爆发脑膜炎 W 病的病例表现和公共卫生应对措施。
Emerg Infect Dis. 2020 Jul;26(7):1355-1363. doi: 10.3201/eid2607.181941.
6
Serogroup A meningococcal conjugate vaccines: building sustainable and equitable vaccine strategies.A 群脑膜炎球菌结合疫苗:构建可持续和公平的疫苗策略。
Expert Rev Vaccines. 2020 May;19(5):455-463. doi: 10.1080/14760584.2020.1760097. Epub 2020 Apr 29.
7
Neisseria meningitidis Serogroup W Meningitis Epidemic in Togo, 2016.2016 年多哥脑膜炎奈瑟菌 W 群脑膜炎疫情。
J Infect Dis. 2019 Oct 31;220(220 Suppl 4):S216-S224. doi: 10.1093/infdis/jiz330.
8
A New Sequence Type of Neisseria meningitidis Serogroup C Associated With a 2016 Meningitis Outbreak in Mali.一种与 2016 年马里脑膜炎爆发相关的 C 群脑膜炎奈瑟菌新型序列型。
J Infect Dis. 2019 Oct 31;220(220 Suppl 4):S190-S197. doi: 10.1093/infdis/jiz272.
9
Rapid response to meningococcal disease cluster in Foya district, Lofa County, Liberia January to February 2018.2018年1月至2月,利比里亚洛法县福亚区对脑膜炎球菌病聚集性疫情的快速应对。
Pan Afr Med J. 2019 May 29;33(Suppl 2):6. doi: 10.11604/pamj.supp.2019.33.2.17095. eCollection 2019.
10
Experience implementing a university-based mass immunization program in response to a meningococcal B outbreak.在应对脑膜炎 B 型疫情时,实施基于大学的大规模免疫接种计划的经验。
Hum Vaccin Immunother. 2019;15(3):717-724. doi: 10.1080/21645515.2018.1547606. Epub 2019 Jan 8.